ID: ALA3245418

Max Phase: Preclinical

Molecular Formula: C30H27I3N6O3

Molecular Weight: 900.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N=C(N)c1ccc(OCc2cc(COc3ccc(C(=N)N)cc3I)cc(COc3ccc(C(=N)N)cc3I)c2)c(I)c1

Standard InChI:  InChI=1S/C30H27I3N6O3/c31-22-10-19(28(34)35)1-4-25(22)40-13-16-7-17(14-41-26-5-2-20(29(36)37)11-23(26)32)9-18(8-16)15-42-27-6-3-21(30(38)39)12-24(27)33/h1-12H,13-15H2,(H3,34,35)(H3,36,37)(H3,38,39)

Standard InChI Key:  HRPSIRFRKQZGFE-UHFFFAOYSA-N

Associated Targets(non-human)

Acrosin 53 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Glandular kallikrein 81 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 900.30Molecular Weight (Monoisotopic): 899.9279AlogP: 6.09#Rotatable Bonds: 12
Polar Surface Area: 177.30Molecular Species: BASEHBA: 6HBD: 6
#RO5 Violations: 3HBA (Lipinski): 9HBD (Lipinski): 9#RO5 Violations (Lipinski): 3
CX Acidic pKa: CX Basic pKa: 11.99CX LogP: 6.22CX LogD: -1.00
Aromatic Rings: 4Heavy Atoms: 42QED Weighted: 0.06Np Likeness Score: -0.21

References

1. Parrish RF, Straus JW, Paulson JD, Polakoski KL, Tidwell RR, Geratz JD, Stevens FM..  (1978)  Structure-activity relationships for the inhibition of acrosin by benzamidine derivatives.,  21  (11): [PMID:722718] [10.1021/jm00209a008]

Source